TL4_Halvorsen
TL4 Leader · Journal club · Bergen, NO
Long-time member, journal club co-chair. I keep the trial digest pages current. I disagree in public and change my mind in public; both are the point.
Joined 8 May 2024 · last posted 22h · groups: journal-club, wiki-editors, trust-level-4
185 posts, newest first. Showing up to 150.
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 27 Jul 2026 · 1 like What I want from this cagrilintide alone thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #64 · Compounds › Secretagogues & GH axis · 26 Jul 2026 · 0 likes Post #63 answers the question as asked. The question underneath it is different. Two people in this thread mean different things by Reading a rodent study and are…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #100 · Practice › Administration · 23 Jul 2026 · 30 likes Answering the question post #99 raises rather than the one it answers. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
-
A structured critique template this community uses — a second dataset Replied, post #45 · Evidence › Study critique · 21 Jul 2026 · 1 like Adding the measurement that post #42 says would settle it. A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is…
-
Insurance and replacement policies, compared Replied, post #104 · Sourcing › Logistics · 20 Jul 2026 · 7 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
What a certificate commits its issuer to Replied, post #51 · Analytics › COA interpretation · 18 Jul 2026 · 7 likes Adding the measurement that post #48 says would settle it. An itemised related-substances table with retention times says considerably more about the synthesis than a…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #40 · Practice › Interactions · 13 Jul 2026 · 1 like The reason Antibiotics is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
-
What a reversed-phase purity number actually is Replied, post #41 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 0 likes Post #37 and I disagree about the size of the effect, not about the direction. What I would check first on reversed-phase purity number is whether the thing being…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #15 · Clinical › Bloodwork · 10 Jul 2026 · 8 likes Post #11 describes the usual case. This is about the unusual one. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
What is genuinely unknown about long-term amylin agonism Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2026 · 22 likes Post #13 is right about the mechanism and I think understates the practical bit. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere…
-
Why I now write the concentration on the vial in marker Replied, post #3 · Practice › Reconstitution · 4 Jul 2026 · 13 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #60 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 30 likes Sensible. I would want the same detail before I acted on it either.
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #34 · Practice › Administration · 29 Jun 2026 · 0 likes Everything in post #31 holds. The case it does not cover is the one I have. Distinguishing three things in the Angle of injection discussion that keep getting used…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #55 · Practice › Dosing & titration · 27 Jun 2026 · 2 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Publication patterns in the BPC-157 literature, examined Replied, post #22 · Compounds › Repair & healing peptides · 27 Jun 2026 · 5 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Micro-titration: a disputed topic, argued properly Replied, post #95 · Practice › Dosing & titration · 25 Jun 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #89 · Sourcing › Vendor reports · 23 Jun 2026 · 15 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. Take it as a starting point…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #31 · Analytics › Method validation · 17 Jun 2026 · 0 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. Where the specificity reasoning breaks down for me is the step from the group…
-
What a good consultation looks like from the other side Replied, post #50 · Clinical › Prescriber conversations · 16 Jun 2026 · 12 likes Post #46 put the caveat in the right place and I want to underline it. A question phrased as "what would you want to see before considering X" is answerable and is not…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #13 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 22 likes That reframing is the whole thing. The facts I already had.
-
Journal club: SELECT, absolute risk, and how it was reported — a second dataset Replied, post #5 · Evidence › Journal club · 13 Jun 2026 · 29 likes Worth starting from what the authors set out to estimate rather than what they reported. Half the disagreements in a session dissolve once that is stated explicitly.…
-
Purity assay versus content assay: two different numbers Replied, post #5 · Analytics › COA interpretation · 9 Jun 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Racemisation and why it is invisible to a mass measurement Replied, post #22 · Analytics › Impurities & related substances · 9 Jun 2026 · 4 likes The question underneath racemisation is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #27 · Start Here › How to Ask · 8 Jun 2026 · 1 like This is the sort of exchange that makes the archive worth searching.
-
How to disagree with an answer you were given, well Replied, post #7 · Start Here › How to Ask · 8 Jun 2026 · 0 likes Say what you want out of the answer. "I want to know whether to accept this delivery" and "I want to understand the chemistry" get very different and equally valid…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #54 · Evidence › Journal club · 7 Jun 2026 · 11 likes Picking up post #51: that is the part I would want checked first. Two things can be true about SURMOUNT-1 at once: the mechanism is plausible and the evidence for the…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #90 · Sourcing › Red flags · 6 Jun 2026 · 30 likes Where the same certificate image appears with different lot numbers, that is a documentation finding worth reporting with the images attached. I would want the raw data…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #63 · Devices › Syringes & needles · 6 Jun 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #22 · Evidence › Meta-analyses · 5 Jun 2026 · 0 likes I read post #18 twice before replying, because I had assumed the opposite. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria.…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #52 · Sourcing › Red flags · 5 Jun 2026 · 0 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. The claim is narrower…
-
Injecting into an area that has become firm: why not to Replied, post #13 · Practice › Administration · 4 Jun 2026 · 10 likes Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly injecting one area changes the local tissue over time and eventually changes…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #32 · Practice › Storage & stability · 3 Jun 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #9 · Compounds › Semaglutide · 3 Jun 2026 · 10 likes On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation. A reconstituted research preparation matches neither, and…
-
Spreadsheets: an appreciation — what changed since Replied, post #58 · Lounge › Off topic · 1 Jun 2026 · 12 likes What I would check first on Spreadsheets is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
An 18-month record including the parts that went badly Replied, post #25 · Outcomes › Progress reports · 26 May 2026 · 13 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding.
-
Private prescribing in the UK: what is actually involved Replied, post #23 · Regional › UK & Ireland · 26 May 2026 · 8 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
The best-written scientific paper you have read Replied, post #60 · Lounge › Off topic · 23 May 2026 · 9 likes Off-topic but genuinely curious: how many people here came in through the analytics side rather than the practical side? The two groups seem to read completely…
-
Micro-titration: a disputed topic, argued properly Replied, post #76 · Practice › Dosing & titration · 18 May 2026 · 0 likes On micro-titration, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Alcohol: what is documented and what is folklore Replied, post #15 · Practice › Interactions · 16 May 2026 · 10 likes I read post #13 twice before replying, because I had assumed the opposite. Two claims get bundled together under alcohol and they need separating. The descriptive one —…
-
Tracking intake honestly when appetite is absent Replied, post #24 · Nutrition & Training › Protein & intake · 13 May 2026 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
A parcel stationary at a customs facility for nine days Replied, post #58 · Sourcing › Logistics · 11 May 2026 · 1 like The arithmetic in post #55 is right; the assumption feeding it is the part to check. A tracking gap at a customs facility is the most common cause of an unexpectedly…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #17 · Evidence › Trials · 10 May 2026 · 11 likes On post #13 — agreed on the reasoning, with one qualification. If you are new and reading this thread for the answer to Primary endpoint hierarchies: the answer is…
-
Request: show the solution author in the topic list — what changed since Replied, post #73 · Meta › Feature requests · 3 May 2026 · 30 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #27 · Devices › Syringes & needles · 29 Apr 2026 · 0 likes Post #23 put the caveat in the right place and I want to underline it. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #43 · Evidence › Journal club · 29 Apr 2026 · 10 likes Whatever the answer on indirect comparison turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
Blind submission and why it changes minds — the long version Replied, post #41 · Sourcing › Independent verification · 25 Apr 2026 · 2 likes Building on post #39 rather than restating it. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #56 · Sourcing › Vendor reports · 25 Apr 2026 · 1 like Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. The honest answer is…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #67 · Analytics › Method validation · 24 Apr 2026 · 15 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #29 · Analytics › Impurities & related substances · 18 Apr 2026 · 8 likes Answering the question post #27 raises rather than the one it answers. A note on how Residual solvents and scavengers gets discussed rather than on Residual solvents…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #16 · Practice › Reconstitution · 15 Apr 2026 · 7 likes Answering the question post #12 raises rather than the one it answers. Write the reconstitution date and the concentration on the vial. Not on a note, on the vial.…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #11 · Analytics › Home & field testing · 15 Apr 2026 · 0 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Second pass at: The storage lookup and where its data comes from Replied, post #5 · Data & Tools › Calculators · 12 Apr 2026 · 0 likes On storage lookup I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #74 · Research Methods › Statistics · 9 Apr 2026 · 31 likes This follows post #73 rather than contradicting it. Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #96 · Clinical › Special populations · 3 Apr 2026 · 3 likes Pregnancy and breastfeeding are the clearest cases where the answer is that the trials excluded them and the labelling reflects that exclusion.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #78 · Practice › Interactions · 3 Apr 2026 · 3 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of…
-
Coming back to: Training through a dose escalation week Replied, post #63 · Nutrition & Training › Resistance training · 27 Mar 2026 · 0 likes Adding a data point of agreement rather than a data point.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #99 · Research Methods › N-of-1 designs · 24 Mar 2026 · 0 likes Where I part company with post #95, and it is a narrow parting. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #83 · Regional › UK & Ireland · 19 Mar 2026 · 0 likes Building on post #82 rather than restating it. Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be…
-
Coming back to: Training through a dose escalation week Replied, post #52 · Nutrition & Training › Resistance training · 15 Mar 2026 · 24 likes Picking up post #51: that is the part I would want checked first. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #65 · Compounds › Cagrilintide & amylin analogues · 14 Mar 2026 · 20 likes On analysis: an amylin analogue and its aggregates are not equally detectable by a standard reversed-phase method, because a large aggregate may not elute at all. Area…
-
Second pass at: Identical chromatograms across two different lots Replied, post #53 · Sourcing › Red flags · 9 Mar 2026 · 0 likes I read the earlier replies on Identical chromatograms twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
-
Research-use-only labelling: what it means and what it does not Replied, post #111 · Sourcing › Regulatory · 3 Mar 2026 · 0 likes The strongest argument against my own position on research-use-only labelling, stated as well as I can state it, since nobody else has yet.
-
About the Method validation category Replied, post #6 · Analytics › Method validation · 26 Feb 2026 · 0 likes Post #2 and I disagree about the size of the effect, not about the direction. Forced degradation studies: deliberately stress the material with acid, base, oxidant,…
-
Measurement error in a self-reported exposure Replied, post #51 · Evidence › Study critique · 24 Feb 2026 · 0 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. It is a…
-
Second pass at: Identical chromatograms across two different lots Replied, post #22 · Sourcing › Red flags · 22 Feb 2026 · 17 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. Caveat: everything above…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #18 · Evidence › Journal club · 17 Feb 2026 · 22 likes Adding the measurement that post #15 says would settle it. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…
-
Splitting an overlong document into two Replied, post #2 · Documentation › Wiki requests · 3 Feb 2026 · 30 likes Splitting an overlong document came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #20 · Practice › Administration · 29 Jan 2026 · 2 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #27 · Practice › Storage & stability · 27 Jan 2026 · 0 likes Post #24 is the version of this I will quote in future. One addition. Adsorptive losses: I have looked for the primary source twice and failed twice. Either it does not…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #10 · Analytics › HPLC & UHPLC · 26 Jan 2026 · 0 likes That is a fair summary of where the discussion has got to.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #46 · Clinical › Special populations · 23 Jan 2026 · 0 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #37 · Evidence › Trials · 20 Jan 2026 · 0 likes I had written a reply contradicting post #35 and deleted it. Here is what survived. The bit of non-inferiority margins that nobody enjoys is that the answer changes…
-
Citation sweep results: how many references did not say what was claimed Replied, post #32 · Meta › Wiki maintenance · 17 Jan 2026 · 16 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #29 · Clinical › Bloodwork · 29 Dec 2025 · 20 likes I had written a reply contradicting post #27 and deleted it. Here is what survived. The most useful thing this subcategory does is help people tell an interesting…
-
Filter needles: when they help and what they cost you Replied, post #11 · Devices › Syringes & needles · 25 Dec 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Adolescents: a distinct evidence base — one year on Replied, post #44 · Clinical › Special populations · 16 Dec 2025 · 0 likes I had written a reply contradicting post #42 and deleted it. Here is what survived. The confident answers on Adolescents and the well-sourced answers are not the same…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #67 · Clinical › Special populations · 14 Dec 2025 · 8 likes One caution on Older adults: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 12 Dec 2025 · 7 likes Symptoms attributed to electrolytes here are non-specific and overlap with dehydration, low intake and poor sleep. Attribution from symptoms alone is unreliable. Worth…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #22 · Compounds › Tirzepatide · 8 Nov 2025 · 18 likes Adding the measurement that post #21 says would settle it. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #71 · Practice › Dosing & titration · 4 Nov 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #16 · Practice › Side effects · 2 Nov 2025 · 2 likes Useful. I have added it to my own notes with the date on it.
-
Reading SURMOUNT-1 without the press release Replied, post #49 · Compounds › Tirzepatide · 30 Oct 2025 · 3 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #24 · Compounds › Other compounds · 29 Oct 2025 · 12 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Sleep tracking data and its considerable limitations Replied, post #45 · Wellbeing › Sleep · 21 Oct 2025 · 0 likes Post #41 describes the usual case. This is about the unusual one. What I can speak to on sleep is narrow, so I will keep it narrow rather than generalising from it.…
-
Dead volume across syringe and needle combinations Replied, post #13 · Devices › Syringes & needles · 19 Oct 2025 · 8 likes Check what the graduations actually say rather than what you expect. A syringe marked in units and one marked in millilitres look similar at a glance and are not the…
-
Payment mechanics and the recovery options that do not exist Replied, post #23 · Sourcing › Payments · 19 Oct 2025 · 24 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
-
A 40-week log with the measurement method stated Replied, post #32 · Outcomes › Progress reports · 18 Oct 2025 · 9 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series. Posted with less confidence than the sentence…
-
Second pass at: Programming during a large energy deficit Replied, post #43 · Nutrition & Training › Resistance training · 17 Oct 2025 · 1 like Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
Sleep tracking data and its considerable limitations Replied, post #12 · Wellbeing › Sleep · 16 Oct 2025 · 9 likes Where I part company with post #10, and it is a narrow parting. Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #103 · Practice › Administration · 10 Oct 2025 · 1 like Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Request: a diff view for wiki revisions — the long version Replied, post #53 · Meta › Feature requests · 8 Oct 2025 · 12 likes I had written a reply contradicting post #50 and deleted it. Here is what survived. Alternatives: if you have thought of a way the current site might already serve your…
-
Temperature loggers worth the money Replied, post #37 · Devices › Cold chain · 3 Oct 2025 · 10 likes Temperature loggers worth the money is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #9 · Compounds › Tirzepatide · 3 Oct 2025 · 2 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Compounds this community declines to help with, and why Replied, post #47 · Compounds › Other compounds · 2 Oct 2025 · 28 likes Dose conversions between related compounds in this subcategory are made far too casually. Structural similarity does not imply potency similarity and frequently does…
-
A preprint whose numbers changed substantially at publication Replied, post #67 · Evidence › Preprints · 26 Sep 2025 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #86 · Evidence › Study critique · 15 Sep 2025 · 8 likes Building on post #83 rather than restating it. The reason Reverse causation is hard to answer is that the obvious measurement and the relevant quantity are not the same…
-
Titles that describe the question, not the situation Replied, post #96 · Start Here › How to Ask · 14 Sep 2025 · 17 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Adding this to the thread rather than…
-
Pooling trials with different estimands — what changed since Replied, post #23 · Evidence › Meta-analyses · 11 Sep 2025 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #4 · Data & Tools › Datasets · 6 Sep 2025 · 16 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #129 · Practice › Storage & stability · 2 Sep 2025 · 9 likes Taking post #128 at face value and following it one step further. Published stability data actually covers was covered in the wiki last year and the page has a review…
-
Column chemistry choices for a 40-residue peptide Replied, post #25 · Analytics › HPLC & UHPLC · 31 Aug 2025 · 1 like Post #23 describes the usual case. This is about the unusual one. System suitability testing: injections run before and during the sample run to establish whether the…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #39 · Practice › Storage & stability · 30 Aug 2025 · 8 likes I read post #35 twice before replying, because I had assumed the opposite. Taking power cut for eleven hours seriously for a moment rather than deflecting: the honest…
-
High-resolution MS on aggregates and what it can see Replied, post #53 · Analytics › Mass spectrometry · 27 Aug 2025 · 0 likes Coming back to post #49, because the follow-up matters more than the original answer. Trying to state the high-resolution position in a way that someone who disagrees…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #7 · Practice › Storage & stability · 20 Aug 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Somebody will…
-
A friction point in the promotion workflow Replied, post #6 · Meta › Site feedback · 18 Aug 2025 · 12 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #37 · Start Here › How to Ask · 11 Aug 2025 · 10 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #93 · Compounds › Retatrutide · 11 Aug 2025 · 8 likes On post #89 — agreed on the reasoning, with one qualification. The hepatic-steatosis rationale follows directly from glucagon receptor agonism promoting fat oxidation…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #15 · Practice › Side effects · 2 Aug 2025 · 25 likes Narrowing post #14, because the general version has more than one answer. The relationship between symptom burden and outcome is not what people assume. Feeling worse…
-
Second pass at: Isotonicity and what happens when you get it wrong Replied, post #4 · Pharmacology › Formulation chemistry · 2 Aug 2025 · 7 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #69 · Data & Tools › Calculators · 1 Aug 2025 · 28 likes Titration planner refuses would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
[2026 update] Cold solution and stinging: the simplest fix Replied, post #6 · Practice › Administration · 31 Jul 2025 · 6 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Travel coolers and how long they really hold Replied, post #5 · Devices › Cold chain · 30 Jul 2025 · 13 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #96 · Compounds › Tirzepatide · 29 Jul 2025 · 0 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
-
Research-use-only labelling: what it means and what it does not Replied, post #16 · Sourcing › Regulatory · 28 Jul 2025 · 0 likes This follows post #13 rather than contradicting it. Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims…
-
Insurance and replacement policies, compared — the long version Started this topic · Sourcing › Logistics · 23 Jul 2025 · 40 likes Insurance and replacement policies, compared — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about Insurance…
-
A field-by-field walk through a certificate of analysis Replied, post #93 · Analytics › COA interpretation · 17 Jul 2025 · 3 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. The number is…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #52 · Regional › UK & Ireland · 10 Jul 2025 · 25 likes This settles it for me, at least until somebody posts a reason it should not.
-
[2026 update] A single out-of-range value on an otherwise normal panel Started this topic · Clinical › Bloodwork · 8 Jul 2025 · 11 likes On the subject in the title: A single out-of-range value on an otherwise normal panel Working notes rather than a conclusion. General question, not a request for advice…
-
High-resolution MS on aggregates and what it can see Replied, post #17 · Analytics › Mass spectrometry · 5 Jul 2025 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #155 · Practice › Reconstitution · 5 Jul 2025 · 18 likes Adding what did not work for me on 5 mg vial, since the failures never get written up and they are half the useful information.
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #51 · Evidence › Trials · 5 Jul 2025 · 23 likes Sample size calculations: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Repeatability versus intermediate precision Replied, post #129 · Analytics › Method validation · 3 Jul 2025 · 3 likes That is the distinction I keep failing to hold on to. Written down now.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #75 · Compounds › Tirzepatide · 22 Jun 2025 · 0 likes Adding the measurement that post #74 says would settle it. Worth stating the null on GIP component of tirzepatide before we explain it: the observation may be nothing.…
-
[2026 update] Sulphur-smelling eructation: mechanism and what helps Replied, post #2 · Practice › Side effects · 17 Jun 2025 · 15 likes Dehydration is the mechanism behind more of the secondary complaints here than people expect. Reduced intake plus vomiting plus a warm week is a straightforward path to…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #96 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 0 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #24 · Nutrition & Training › Protein & intake · 5 Jun 2025 · 26 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #59 · Outcomes › Progress reports · 30 May 2025 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #10 · Pharmacology › Pharmacokinetics · 22 May 2025 · 15 likes Noted, and I have changed what I was going to do on the strength of it.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #17 · Analytics › Home & field testing · 19 May 2025 · 6 likes Post #13 describes the usual case. This is about the unusual one. Offering a way to settle quantitation rather than another opinion about it. Two measurements, taken…
-
Pages past their review date, listed — does this still hold? Started this topic · Meta › Wiki maintenance · 2 May 2025 · 0 likes Pages past their review date, listed — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #66 · Practice › Interactions · 29 Apr 2025 · 0 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #42 · Practice › Reconstitution · 24 Apr 2025 · 1 like Narrowing post #41, because the general version has more than one answer. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #27 · Practice › Storage & stability · 23 Apr 2025 · 3 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Counterpoint on published stability data actually covers, offered without…
-
Reading a trial's population section before its results — does this still hold? Replied, post #13 · Evidence › Trials · 15 Apr 2025 · 0 likes Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally better than adherence outside them. Reporting the observation…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #27 · Regional › UK & Ireland · 3 Apr 2025 · 27 likes I read post #25 twice before replying, because I had assumed the opposite. Where guidance distinguishes between indications, quoting the indication is essential. The…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #28 · Sourcing › Vendor reports · 27 Mar 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #115 · Pharmacology › Receptor biology · 17 Mar 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Maintainer handover: how it works Replied, post #49 · Meta › Wiki maintenance · 16 Mar 2025 · 0 likes Whatever the answer on maintainer handover turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #2 · Sourcing › Vendor reports · 16 Mar 2025 · 4 likes Taking the opening post at face value and following it one step further. Reports of ordinary results are more valuable than reports of remarkable ones, precisely…
-
Charge states for a 4 kDa peptide, worked through Replied, post #119 · Analytics › Mass spectrometry · 16 Mar 2025 · 20 likes Post #118 answers the question as asked. The question underneath it is different. For anyone finding this later: the short answer on charge states is that it depends on…
-
Certificates issued by the seller versus by a laboratory Replied, post #6 · Analytics › COA interpretation · 14 Mar 2025 · 28 likes Thank you — that answers what I came here to find out.
-
Consistent declarations and why they matter more than clever ones Replied, post #161 · Sourcing › Logistics · 10 Mar 2025 · 0 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. Two people can read the same figure differently here…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #35 · Compounds › Oral incretins · 10 Mar 2025 · 10 likes Thank you for the correction. I would rather find out here than later.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #128 · Sourcing › Regulatory · 5 Mar 2025 · 6 likes Post #126 put the caveat in the right place and I want to underline it. If you can confirm or contradict a position for your own region, please date the answer. An…
-
Consistent declarations and why they matter more than clever ones Replied, post #125 · Sourcing › Logistics · 4 Mar 2025 · 28 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. The general answer and the answer for your case may…
-
Follow-up: Requesting a page: what makes a good request Replied, post #6 · Documentation › Wiki requests · 1 Mar 2025 · 0 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
-
A promotion I argued against, and why I lost Replied, post #113 · Documentation › Doc review · 27 Feb 2025 · 12 likes Post #112 answers the question as asked. The question underneath it is different. Two questions I would want answered before drawing anything from the promotion data…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #55 · Wellbeing › Mental health · 27 Feb 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #90 · Compounds › Other compounds · 15 Feb 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
A supplier that answers analytical questions with restated claims Replied, post #17 · Sourcing › Red flags · 30 Jan 2025 · 7 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them. If anyone can point at the primary…